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Sudden unexplained death in epilepsy (SUDEP) is 
a major cause of mortality in patients with epilepsy1,2. 
The aetiology of SUDEP remains unclear and may be 
multifactorial. Autonomic dysfunction affecting car-
diac or pulmonary systems has been postulated as a 
major factor in SUDEP. Cardiac rate and rhythm dis-
turbances and respiratory abnormalities have been 
identified during seizures3-6. Seizures can alter respi-
ratory rate and pattern, producing tachypnoea, hy-
popnoea or apnoea, and secretions. Apnoea is com-
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AbSTrACT - Dysfunction affecting cardiac or pulmonary systems has been postulated as a major factor in 
sudden death in epilepsy (SUDEP). Whilst the majority of studies of cardiorespiratory function have focused 
on changes during seizures, here we investigate whether epilepsy influences basal respiratory parameters 
in patients with temporal lobe epilepsy (TLE) during the interictal period. Spirometry was performed in 10 
females and 10 males. Measurements of Vital Capacity (VC), Forced Vital Capacity (FVC), Forced Expirato-
ry Volume in the first second (FEV1) and ratios of FEV1 to FVC (FEV1/FVC) were obtained, and these val-
ues were analyzed as percentages of predicted values. None of the patients had chronic obstructive pul-
monary disease and no significant alterations in respiratory function tests were found among these pa-
tients. No association between seizure frequency, antiepileptic drugs and SUDEP could be found in this 
study. Although the study did not identify any specific respiratory abnormality in TLE patients during the 
interictal period, re-evaluation of clinical data on pulmonary disorders in people with epilepsy should be 
better investigated. 
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rESUMo - Alterações cardíacas e pulmonares têm sido propostas como principais fatores de risco no fenô-
meno da morte súbita em epilepsia (SUDEP). Enquanto a maioria dos estudos tem verificado as alterações 
da função cardiorrespiratória durante as crises epilépticas, nosso estudo avaliou a função pulmonar de in-
divíduos com epilepsia do lobo temporal (ELT) no período interictal. Vinte pacientes com ELT (10 homens 
e 10 mulheres) participaram de nosso estudo. Nos testes de função pulmonar foram mensurados os seguin-
tes parâmetros: Capacidade Vital Forçada (CVF), Capacidade Vital Lenta (CVL), Volume Expiratório Forçado 
no primeiro segundo (VEF1) e o Índice VEF1/CVF. os resultados foram comparados aos valores de norma-
lidade preditos na literatura. Nenhum dos pacientes apresentou doença pulmonar obstrutiva ou restritiva 
e alterações significativas nos testes de função pulmonar. Não foram encontradas associações entre a fre-
qüência de crises, drogas antiepilépticas e SUDEP. Embora nosso estudo não tenha identificado qualquer 
anormalidade respiratória específica em indivíduos com ELT durante o período interictal, os dados clínicos 
sobre transtornos pulmonares em indivíduos com epilepsia devem ser melhor avaliados.
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mon during tonic-clonic seizure and brief apnoea 
occurs during many complex partial seizures4. Stud-
ies using video-EEG monitoring have shown pulmo-
nary dysfunction in patients with epilepsy when a 
life-threatening period or death occurs7-9. Pulmonary 
oedema is the result of an increase in pulmonary vas-
cular pressure from increased sympathetic activity, 
provoking the combination of pulmonary vasocon-
striction and increased left atrial pressure from sys-
temic hypertension. Status epilepticus and repetitive 
seizures can cause pulmonary oedema, which can al-
ter pulmonary function for up to 72 hours10. Studies 
have shown that seizure-associated respiratory com-
promise due to hypoventilation or obstructive ap-
noea is an important feature in SUDEP4,11. In a se-
ries of 15 witnessed SUDEPs, respiratory difficulties 
were seen in 1211. Although various abnormalities in 
pulmonary cardiac functions that can cause sudden 
death during the ictal period in patients with epilep-
sy have been reported12-14, there are only a few re-
ports with respect to the interictal period15.
We aimed to assess whether patients with epilep-
sy have higher respiratory co-morbidity than the gen-
eral population, and whether the prevalence of re-
spiratory co-morbidity differs between people with 
epilepsy with and without known risk factors for 
SUDEP. Whereas most available studies of cardiore-
spiratory function have focused on changes during 
seizures5,13, here we investigate whether epilepsy in-
fluences pulmonary function. We analyzed respirato-
ry parameters in patients with temporal lobe epilep-
sy (TLE), the most frequent refractory epilepsy, dur-
ing the interictal period.
method
Adult outpatients with medically proven TLE were invit-
ed to participate as study subjects during a routine visit to 
a specified neurological outpatient clinic (Itapeti Neuroclin-
ic, Mogi das Cruzes, brazil). Patients were informed about 
the procedures of the study, and if agreed to take part in 
the study signed an informed consent form. The study was 
ethically reviewed and approved by the Institutional hu-
man research Ethics Committee. 
Inclusion criteria were age over 18 years, a reliable diag-
nosis of TLE, ability to read and comprehend the meaning 
of the questionnaire and able to provide informed consent 
to participate in the study. Patients with a clinical diagno-
sis of asthma, allergic rhinitis, smoking habits, and other 
respiratory disorders were excluded. All had a multidisci-
plinary evaluation, including history and physical exami-
nation, EEG monitoring and magnetic resonance imaging 
(MrI). In brief, thirteen patients presented psychic seizures 
within complex partial seizures: nine with epigastric aura 
and four with affective manifestations of fear. These events 
occurred before anti-epileptic drugs (AED) treatment. EEG 
analysis with scalp electrodes performed during sleep and 
wakefulness showed epileptiform activity with spike waves 
predominantly in the anterior temporal region in nine pa-
tients, focal EEG slowness in the temporal regions in two 
patients and normal EEG in nine patients. MrI showed hip-
pocampal atrophy in nine patients. 
Spirometry was performed in 10 females and 10 males. 
All completed a questionnaire about age, sex and health 
habits. body measurements were taken, including stand-
ing height and weight. After explanation of the test pro-
cedures, every subject attempted to perform spirometric 
manoeuvres. Forced expiratory manoeuvres were record-
ed with a pneumotachograph (Koko Spirometer). A mini-
mum of 3 acceptable and reproducible manoeuvres were 
obtained for each patient, according to the standards rec-
ommended by the American Thoracic Society16. All spiro-
metric examinations were carried out with the subject seat-
ed, wearing a nose clip and using a disposable mouthpiece. 
The technical procedures, acceptable criteria, and repro-
ducibility followed American Thoracic Society guidelines17. 
Measurements for Forced Vital Capacity (FVC), Forced Expi-
ratory Volume in the first second (FEV1) and ratios of FEV1 
to FVC (FEV1/FVC) were obtained, and these values were 
compared with predicted values. reference values from 
Crapo18 and rodrigues19 were used.
Statistical analysis – Statistical analysis was done by em-
ploying the ANoVA test with Tukey post test. Significance 
was established at the p<0.05 level.
results
None of the 20 patients with TLE had chronic ob-
structive pulmonary disease. Anthropometrics and 
clinical characteristics of the patients with epilepsy 
in the study are shown in the Table. The mean age 
of the patients was 41±12.3 years and the mean du-
ration of epilepsy was 20±9 years. All patients were 
treated with AEDs, using at least one medication at 
the time of the study. Carbamazepine (80%) was 
the most commonly used AED, followed by cloba-
zam (10%). Almost all patients presented with con-
trolled seizures. Pulmonary function of patients with 
epilepsy showed no significant alterations in respi-
ratory tests: FVC (4.09±1.24), FEV1 (3.33±1.03) and 
FEV1/FVC (0.81±0.05). No association between sei-
zure frequency, AED and altered pulmonary func-
tion was found.
discussion
Potential mechanisms of SUDEP comprise cardiac 
arrhythmia, autonomic imbalance, hypoxia, arrhyth-
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mogenic drugs or central or obstructive apnoea4,20-22. 
We analyzed respiratory parameters in patients with 
TLE during the interictal period and found no signifi-
cant alterations in respiratory function tests. 
The exact pathomechanism of SUDEP is unknown. 
Cardiac mechanisms may play a role, due to repetitive 
cardiac damage during seizures and to arrhythmia 
during seizures, possibly triggered by apnoea and/ or 
cerebral autonomic imbalance. Several studies deal 
with respiratory parameters during seizures4,15,23 but 
information on respiratory function in patients with 
epilepsy during the interictal period is lacking. one 
study15 found vital capacity levels to be significantly 
lower in patients with generalized epilepsy than in 
those with partial epilepsy. respiratory physicians de-
tected no pathology during examinations of patients, 
so the differences found in vital capacity were evalu-
ated as a lack of coordination in respiratory func-
tion tests. Another group also observed that respira-
tory function tests in the interictal period were no 
different from those of a control group14. Informa-
tion about the interictal period was also analysed in 
animals with pilocarpine-induced epilepsy24. In this 
study rats with epilepsy presented an altered ability 
to compensate for changes in arterial gas levels with 
changes in ventilation in response to an increase or 
decrease in PaCo2. 
Although data from literature have showed sei-
zure control in 10-40% of TLE patients, we observed 
that 75% of the patients from our study presented 
controlled seizure under therapy treatment. one ex-
planation for our findings might be that most pa-
tients in this study had controlled seizures, and in-
creased seizure frequency is reported to be a strong 
risk factor for SUDEP. Most of our patients, however, 
were taking AED polytherapy, another known risk 
factor for SUDEP.  
Several autopsy studies in people with SUDEP 
have reported pulmonary oedema25 or increased 
lung weights14. The post-mortem data in one study26 
revealed bronchial fluid or pulmonary oedema in 
four of six cases, suggesting that the increased auto-
nomic stimulation associated with seizures in SUDEP 
observed in their study may contribute to pulmonary 
changes that may be important in SUDEP; pre-exist-
ing pulmonary diseases could exacerbate this pro-
cess.
It might be speculated that ictal as well as interic-
tal ventilatory dysfunction could have a role in some 
SUDEP cases. Although our study did not identify 
any specific common respiratory abnormality in TLE 
patients during the interictal period, re-evaluation 
of clinical data about pulmonary disorders in people 
with epilepsy should be better investigated.
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AED 
  Carbamazepine 
  oxcarbazepine 
  Divalproex 
  Phenobarbital 
  Clobazam 
  Clonazepam 
  Nitrazepam 
  hidantoine
 
12 (60%) 
4 (20%) 
1 (5%) 
1 (5%) 
5 (25%) 
3 (15%) 
2 (10%) 
1 (5%)
Therapy treatment 
  Monotherapy 
  Polytherapy
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SPS, simple partial seizure; CPS, complex partial seizure.
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